Logo image of SPXC

SPX TECHNOLOGIES INC (SPXC) Stock Fundamental Analysis

NYSE:SPXC - New York Stock Exchange, Inc. - US78473E1038 - Common Stock - Currency: USD

180.82  +5.41 (+3.08%)

After market: 180.82 0 (0%)

Fundamental Rating

4

Taking everything into account, SPXC scores 4 out of 10 in our fundamental rating. SPXC was compared to 127 industry peers in the Machinery industry. While SPXC belongs to the best of the industry regarding profitability, there are concerns on its financial health. SPXC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

SPXC had positive earnings in the past year.
Each year in the past 5 years SPXC has been profitable.
Of the past 5 years SPXC 4 years had a positive operating cash flow.
SPXC Yearly Net Income VS EBIT VS OCF VS FCFSPXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

SPXC has a better Return On Assets (6.46%) than 62.99% of its industry peers.
SPXC's Return On Equity of 14.04% is fine compared to the rest of the industry. SPXC outperforms 66.93% of its industry peers.
SPXC has a Return On Invested Capital of 9.04%. This is in the better half of the industry: SPXC outperforms 61.42% of its industry peers.
SPXC had an Average Return On Invested Capital over the past 3 years of 7.42%. This is below the industry average of 10.88%.
The last Return On Invested Capital (9.04%) for SPXC is above the 3 year average (7.42%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.46%
ROE 14.04%
ROIC 9.04%
ROA(3y)3.69%
ROA(5y)6.3%
ROE(3y)7.34%
ROE(5y)15.21%
ROIC(3y)7.42%
ROIC(5y)6.2%
SPXC Yearly ROA, ROE, ROICSPXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

SPXC has a better Profit Margin (10.13%) than 69.29% of its industry peers.
SPXC's Profit Margin has improved in the last couple of years.
SPXC has a better Operating Margin (15.66%) than 74.80% of its industry peers.
SPXC's Operating Margin has improved in the last couple of years.
SPXC has a better Gross Margin (40.59%) than 74.02% of its industry peers.
SPXC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.66%
PM (TTM) 10.13%
GM 40.59%
OM growth 3Y33.6%
OM growth 5Y16.47%
PM growth 3Y-33.83%
PM growth 5Y16.81%
GM growth 3Y4.4%
GM growth 5Y6.86%
SPXC Yearly Profit, Operating, Gross MarginsSPXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SPXC is destroying value.
Compared to 1 year ago, SPXC has more shares outstanding
SPXC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SPXC has an improved debt to assets ratio.
SPXC Yearly Shares OutstandingSPXC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SPXC Yearly Total Debt VS Total AssetsSPXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

SPXC has an Altman-Z score of 4.25. This indicates that SPXC is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of SPXC (4.25) is better than 67.72% of its industry peers.
A Debt/Equity ratio of 0.65 indicates that SPXC is somewhat dependend on debt financing.
SPXC's Debt to Equity ratio of 0.65 is on the low side compared to the rest of the industry. SPXC is outperformed by 65.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Altman-Z 4.25
ROIC/WACC0.92
WACC9.88%
SPXC Yearly LT Debt VS Equity VS FCFSPXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

SPXC has a Current Ratio of 1.88. This is a normal value and indicates that SPXC is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.88, SPXC perfoms like the industry average, outperforming 41.73% of the companies in the same industry.
A Quick Ratio of 1.24 indicates that SPXC should not have too much problems paying its short term obligations.
SPXC's Quick ratio of 1.24 is in line compared to the rest of the industry. SPXC outperforms 50.39% of its industry peers.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.24
SPXC Yearly Current Assets VS Current LiabilitesSPXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

6

3. Growth

3.1 Past

SPXC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.38%, which is quite impressive.
The Earnings Per Share has been growing by 15.24% on average over the past years. This is quite good.
SPXC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.94%.
Measured over the past years, SPXC shows a small growth in Revenue. The Revenue has been growing by 5.40% on average per year.
EPS 1Y (TTM)23.38%
EPS 3Y31.31%
EPS 5Y15.24%
EPS Q2Q%10.4%
Revenue 1Y (TTM)13.94%
Revenue growth 3Y17.61%
Revenue growth 5Y5.4%
Sales Q2Q%3.74%

3.2 Future

Based on estimates for the next years, SPXC will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.43% on average per year.
The Revenue is expected to grow by 8.39% on average over the next years. This is quite good.
EPS Next Y15.39%
EPS Next 2Y13.7%
EPS Next 3Y15.21%
EPS Next 5Y13.43%
Revenue Next Year11.82%
Revenue Next 2Y9.38%
Revenue Next 3Y8.29%
Revenue Next 5Y8.39%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SPXC Yearly Revenue VS EstimatesSPXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
SPXC Yearly EPS VS EstimatesSPXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 31.72, the valuation of SPXC can be described as expensive.
SPXC's Price/Earnings ratio is a bit more expensive when compared to the industry. SPXC is more expensive than 63.78% of the companies in the same industry.
SPXC's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.04.
With a Price/Forward Earnings ratio of 25.11, SPXC can be considered very expensive at the moment.
SPXC's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. SPXC is more expensive than 61.42% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SPXC to the average of the S&P500 Index (37.64), we can say SPXC is valued slightly cheaper.
Industry RankSector Rank
PE 31.72
Fwd PE 25.11
SPXC Price Earnings VS Forward Price EarningsSPXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SPXC indicates a slightly more expensive valuation: SPXC is more expensive than 66.93% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.64
SPXC Per share dataSPXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SPXC does not grow enough to justify the current Price/Earnings ratio.
SPXC has a very decent profitability rating, which may justify a higher PE ratio.
SPXC's earnings are expected to grow with 15.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.06
PEG (5Y)2.08
EPS Next 2Y13.7%
EPS Next 3Y15.21%

More info and screens

0

5. Dividend

5.1 Amount

SPXC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPX TECHNOLOGIES INC

NYSE:SPXC (7/25/2025, 8:26:33 PM)

After market: 180.82 0 (0%)

180.82

+5.41 (+3.08%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-31 2025-07-31/amc
Inst Owners94.98%
Inst Owner Change-0.63%
Ins Owners3.24%
Ins Owner Change7.56%
Market Cap8.45B
Analysts87.69
Price Target189.92 (5.03%)
Short Float %2.14%
Short Ratio4.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.73%
Min EPS beat(2)-1.85%
Max EPS beat(2)15.31%
EPS beat(4)3
Avg EPS beat(4)6.29%
Min EPS beat(4)-1.85%
Max EPS beat(4)15.31%
EPS beat(8)6
Avg EPS beat(8)8.98%
EPS beat(12)10
Avg EPS beat(12)14.23%
EPS beat(16)13
Avg EPS beat(16)11.37%
Revenue beat(2)0
Avg Revenue beat(2)-1.81%
Min Revenue beat(2)-1.83%
Max Revenue beat(2)-1.78%
Revenue beat(4)0
Avg Revenue beat(4)-2.26%
Min Revenue beat(4)-5.31%
Max Revenue beat(4)-0.12%
Revenue beat(8)3
Avg Revenue beat(8)-0.87%
Revenue beat(12)7
Avg Revenue beat(12)1.46%
Revenue beat(16)7
Avg Revenue beat(16)0.38%
PT rev (1m)6.3%
PT rev (3m)13.26%
EPS NQ rev (1m)-0.26%
EPS NQ rev (3m)-5.45%
EPS NY rev (1m)-0.19%
EPS NY rev (3m)2.71%
Revenue NQ rev (1m)-0.27%
Revenue NQ rev (3m)0.67%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)2.49%
Valuation
Industry RankSector Rank
PE 31.72
Fwd PE 25.11
P/S 4.22
P/FCF N/A
P/OCF N/A
P/B 5.85
P/tB N/A
EV/EBITDA 22.64
EPS(TTM)5.7
EY3.15%
EPS(NY)7.2
Fwd EY3.98%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS42.85
BVpS30.9
TBVpS-7.72
PEG (NY)2.06
PEG (5Y)2.08
Profitability
Industry RankSector Rank
ROA 6.46%
ROE 14.04%
ROCE 11.81%
ROIC 9.04%
ROICexc 9.68%
ROICexgc 33.47%
OM 15.66%
PM (TTM) 10.13%
GM 40.59%
FCFM N/A
ROA(3y)3.69%
ROA(5y)6.3%
ROE(3y)7.34%
ROE(5y)15.21%
ROIC(3y)7.42%
ROIC(5y)6.2%
ROICexc(3y)7.93%
ROICexc(5y)6.67%
ROICexgc(3y)26.34%
ROICexgc(5y)19.42%
ROCE(3y)9.52%
ROCE(5y)8.03%
ROICexcg growth 3Y80.68%
ROICexcg growth 5Y32.98%
ROICexc growth 3Y48.19%
ROICexc growth 5Y15.92%
OM growth 3Y33.6%
OM growth 5Y16.47%
PM growth 3Y-33.83%
PM growth 5Y16.81%
GM growth 3Y4.4%
GM growth 5Y6.86%
F-ScoreN/A
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Debt/EBITDA 2.3
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.88
Quick Ratio 1.24
Altman-Z 4.25
F-ScoreN/A
WACC9.88%
ROIC/WACC0.92
Cap/Depr(3y)37.86%
Cap/Depr(5y)37.56%
Cap/Sales(3y)1.46%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.38%
EPS 3Y31.31%
EPS 5Y15.24%
EPS Q2Q%10.4%
EPS Next Y15.39%
EPS Next 2Y13.7%
EPS Next 3Y15.21%
EPS Next 5Y13.43%
Revenue 1Y (TTM)13.94%
Revenue growth 3Y17.61%
Revenue growth 5Y5.4%
Sales Q2Q%3.74%
Revenue Next Year11.82%
Revenue Next 2Y9.38%
Revenue Next 3Y8.29%
Revenue Next 5Y8.39%
EBIT growth 1Y40.05%
EBIT growth 3Y57.13%
EBIT growth 5Y22.75%
EBIT Next Year29.82%
EBIT Next 3Y14.68%
EBIT Next 5Y15.57%
FCF growth 1Y34.29%
FCF growth 3Y14.53%
FCF growth 5Y13.64%
OCF growth 1Y37.12%
OCF growth 3Y17.87%
OCF growth 5Y13.98%